Essential |
>20 wk gestation |
New hypertension: systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg on two occasions |
Hypertension: |
• In women without chronic hypertension: as for preeclampsia |
• In women with chronic hypertension: no diagnostic threshold, de novo severe BP (systolic BP >160 mm Hg or diastolic BP >110 mm Hg) or an increase in treatment to maintain BP<160/110 mm Hg used in research cohorts (5,9) |
Additional |
Proteinuria: |
Proteinuria: |
• UPCR≥0.3 mg/mg (>30 mg/mmol) |
• In women with nonproteinuric CKD: as for preeclampsia |
• >300 mg/24 h (not indicated if UPCR available) |
• In women with proteinuric CKD: no diagnostic threshold, |
• Dipstick >2+ (if other methods unavailable) |
>100% increase and UPCR≥0.3 mg/mg (>30 mg/mmol) used in research cohorts (5,9) |
• UACR>70 mg/g (>8 mg/mmol) (54,75) |
Serum creatinine: |
Serum creatinine: |
• Serum creatinine >1.0a to 1.1 mg/dlb,c
|
• In women with CKD and preserved excretory function: as for preeclampsia |
• Doubling of serum creatinine <1.1 mg/dlb,c
|
• In women with CKD and abnormal prepregnancy function: no consensus on diagnostic threshold for change in creatinine, >50% increase within 7 d used in research cohorts (5) |
Hematologic complications: |
|
• Platelets <100b–150a×109/Lc
|
|
• Hemolysisc, disseminated intravascular coagulationc
|
Liver complications: |
• AST or ALT >40 IU/La or double normal reference limitb,c
|
• Epigastric/right upper quadrant pain (not attributable to alternate diagnosis)c
|
Neurologic complications: |
• Eclampsiac
|
• Altered mental statusc
|
• Blindness, persistent visual scotomatac
|
• Strokec
|
• Clonus |
• New-onset headache not attributable to alternate diagnosisc
|
Respiratory complications: |
• Pulmonary edema not attributable to another diagnosisc
|
Uteroplacental dysfunction: |
• Fetal growth restriction, abnormal umbilical artery Doppler waveform, stillbirth |